Gentile, M, Shanafelt, TD, Mauro, FR, Reda, G, Rossi, D, Laurenti, L, Del Principe, MI, Cutrona, G, Angeletti, I, Coscia, M, Herishanu, Y, Chiarenza, A, Molica, S, Ciolli, S, Goldschmidt, N, Angrilli, F, Giordano, A, Rago, A, Bairey, O, Tripepi, G, Chaffee, KG, Sameer, PA, Vigna, E, Zirlik, K, Shvidel, L, Innocenti, I, Recchia, AG, Di Raimondo, F, Del Poeta, G, Cortelezzi, A, Neri, A, Ferrarini, M, Gaidano, G, Kay, NE, Polliack, A, Foà, R & Morabito, F 2018, '
Predictive value of the CLL-IPI in CLL patients receiving chemo-immunotherapy as first-line treatment',
European Journal of Haematology, vol. 101, no. 5, pp. 703-706.
https://doi.org/10.1111/ejh.13149